Biomechanical Study of Different Prostheses for Unilateral Transtibial Amputees During Indoor and Outdoor Activities

September 8, 2025 updated by: YICK Kit Lun, The Hong Kong Polytechnic University

The goal of this observational study is to evaluate and compare the performance of two prosthetic feet for unilateral transtibial amputees during both indoor and outdoor activities. The main research questions aim to answer are:

  1. Can a low-cost prosthetic foot enhance gait mechanics and physical performance in individuals who have undergone traumatic unilateral transtibial amputation, as compared to the traditional K2 - K3 prosthetic feet currently available on the market, during both indoor and outdoor activities?
  2. Can the low-cost prosthetic foot meet user satisfaction levels after traumatic unilateral transtibial amputation, when compared to the traditional K2 - K3 prosthetic foot on the market?

Participants will be asked to do

  1. Prior to the commencement of the experiment, a professional prosthetist and orthotist will conduct all fitting and alignment procedures for the transtibial amputees. Participants will then be given a two to three-week period to train and acclimate to the individual socket alignment and prosthetic foot.
  2. Participants are asked to refrain from consuming caffeine or any stimulants for 24 hours before the tests.
  3. Participants will be required to perform the Berg Balance Test.
  4. Participants will undergo a series of clinical tests, including: 1) Time to Go Up (measured in seconds), 2) Four Square Step Test (measured in seconds), 3) 10-Meter Walk Test (measured in seconds), 4) Eye Close Standing, 5) Tandem Test, and 6) Functional Reach Test. Each test will be conducted three times. The test items of 4) and 5) will be performed on a force plate (Bertect, Ohio, USA) with dimensions of 400 x 600 mm and a capturing frequency of 1,000 Hz.
  5. Participants will be asked to walk on a force plate (AMTI, Advanced Mechanical Technology, Inc., Watertown, USA) at a fixed walking speed of 1.11 ± 0.11m/s, allowing the foot to land naturally on the force plate. Five trials of the gait cycle with a clean foot will be used for analysis.
  6. Participants will perform the Counter Movement Jump Test three times with maximum effort on the force plate (Bertect, Ohio, USA), which will be performed without a hand swing.
  7. Participants will be asked to perform a 2-minute walking test on flat concrete ground, stairs, and a ramp, respectively.
  8. Finally, participants will be asked to complete the Locomotion Capabilities Index questionnaire.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Thirty-nine passive-reflective markers of 14 mm in diameter were placed on the participant (Figure 1) according to the landmarks set of the plug-in full body model. An 8-camera motion capturing system (VICON, Nexus 2.0 Inc., Oxford, UK) and 2 force plates (AMTI, Advanced Mechanical Technology, Inc., Watertown, USA) mounted under the walkway were utilized for gait analysis and recorded 100 frames per second simultaneously. All the systems were calibrated before the experiment.

Study Type

Observational

Enrollment (Actual)

6

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hong Kong
      • Kowloon, Hong Kong, Hong Kong, 999077
        • The Hong Kong Polytechnic University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Six unilateral transtibial amputees (two females and four males) (age: (mean ± SD) 52.5 ± 12.1 years; height: 170.5 ± 10.5 cm; weight: 71.5 ± 6.5 kg; years using a prosthetic: 31 ± 10.8 years) were recruited in this study.

Description

Inclusion Criteria:

  • unilateral transtibial amputees,
  • with more than 12 months of experience using a prosthesis,
  • with a K2 prosthesis or above,
  • be able to walk continuously unaided with the prosthetic foot for at least 20 minutes.

Exclusion Criteria:

  • with a short or an injured residual limb,
  • pregnant,
  • any neurological or musculoskeletal diseases,
  • have a record of active endocarditis and acute myocarditis/pericarditis,
  • experience ongoing unstable angina,
  • have uncontrolled cardiac arrhythmia with hemodynamic compromise,
  • have had a recent stroke or transient ischemic attack,
  • have high blood pressure, etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
K2 or above prosthesis
Unilateral transtibial amputees will engage in both indoor and outdoor activities, utilizing their own prosthesis (control).
Experimental prosthetic foot.
A low-cost prosthesis
Unilateral transtibial amputees will engage in both indoor and outdoor activities, utilizing an experimental prosthesis
Experimental prosthetic foot.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Basic mobility function with two prostheses by Four Square Step Test
Time Frame: up to 12 weeks
Participants will be invited to visit the laboratory twice to participate in two prostheses will be compared by conducting Four Square Step Test (seconds).
up to 12 weeks
Basic mobility function with two prostheses by 10-meter Walk Test
Time Frame: up to 12 weeks
Participants will be invited to visit the laboratory twice to participate in two prostheses will be compared by conducting 10-Meter Walk Test (m/s).
up to 12 weeks
Stability index with two prostheses by Eye Close Standing
Time Frame: up to 12 weeks
Participants will be invited to the laboratory twice to participate in an experiment. In each session, they will be required to perform the Eye Close Standing on a force plate (Bertect, Ohio, USA). The test will be conducted three times, with each attempt lasting 30 seconds. Participants will perform the task using either a low-cost prosthesis or their own prosthetic foot. The averaged anterior-posterior stability index (mm), and medial-lateral stability index (mm) will be calculated automatically by Noraxon software for each task to assess the ability of maintaining posture stability with two prostheses.
up to 12 weeks
Stability index with two prostheses by Tandem Test
Time Frame: up to 12 weeks
Participants will be invited to the laboratory twice to participate in an experiment. In each session, they will be required to perform the Tandem Test on a force plate (Bertect, Ohio, USA). The test will be conducted three times, with each attempt lasting 30 seconds. Participants will perform the task using either a low-cost prosthesis or their own prosthetic foot. The averaged anterior-posterior stability index (mm), and medial-lateral stability index (mm) will be calculated automatically by Noraxon software for each task to assess the ability of maintaining posture stability with two prostheses.
up to 12 weeks
Functional Reach Test
Time Frame: up to 12 weeks
Participants will move from the vertical standing position to the maximum lean forward position, with the feet firmly placed on the floor with either prosthetic foot for three times. The averaged distance (cm) with two prostheses will be compared.
up to 12 weeks
Jump feasibility with two prostheses
Time Frame: up to 12 weeks
Participants will be invited to visit the laboratory twice to participate in an experiment. During each visit, they will be asked to perform the countermovement jump on the force plate (Bertect, Ohio, USA) for three times, using either a low-cost prosthesis or their own prosthetic foot. The average of three times jump height, vertical ground reaction force during different jump phases with two different prostheses will be compared.
up to 12 weeks
Basic mobility function with two prostheses by Berg Balance Test
Time Frame: up to 12 weeks
Participants will be invited to visit the laboratory twice to participate in two prostheses will be compared by conducting Berg Balance Test including 14 items, each item is graded using a 5-point ordinal scale ranging from 0 to 4. 0-20 indicates high fall risk, 21-40 indicates medium fall risk, 41-56 indicates low fall risk.
up to 12 weeks
Basic mobility function with two prostheses by Time to Go Up
Time Frame: up to 12 weeks
Participants will be invited to visit the laboratory twice to participate in two prostheses will be compared by conducting Time to Go Up (seconds), including stand up from chair, walk 3 meters, turn around and back, then sit. Longer than 13.5 seconds indicates high risk of fall.
up to 12 weeks
Gait analysis with two prostheses
Time Frame: up to 12 weeks
For collecting the kinematic and kinetic data for gait analysis, thirty-nine passive-reflective markers were placed on the participant according to the landmarks set of the plug-in full body model. An 8-camera motion capturing system (VICON, Nexus 2.0 Inc., Oxford, UK) and 2 force plates (AMTI, Advanced Mechanical Technology, Inc., Watertown, USA) mounted under the walkway were recorded 100 frames per second simultaneously. All the systems were calibrated before the experiment. Participants will be asked to walk on a force plate (AMTI, Advanced Mechanical Technology, Inc., Watertown, USA) at a fixed walking speed of 1.11 ± 0.11m/s, allowing the foot to land naturally on the force plate. Five trials of the gait cycle with a clean foot will be used for analysis.
up to 12 weeks
Subjective evaluation by Locomotion Capabilities Index questionnaire
Time Frame: up to 12 weeks
Participants will be asked to complete the Locomotion Capabilities Index questionnaire including 14 items, each item is rated with a 5-level scale. 0 indicates unable to perform, 4 indicates no difficulty.
up to 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kit-lun Yick, PhD, The Hong Kong Polytechnic University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 30, 2023

Primary Completion (Actual)

April 30, 2024

Study Completion (Actual)

June 30, 2024

Study Registration Dates

First Submitted

March 13, 2024

First Submitted That Met QC Criteria

April 26, 2024

First Posted (Actual)

April 29, 2024

Study Record Updates

Last Update Posted (Estimated)

September 15, 2025

Last Update Submitted That Met QC Criteria

September 8, 2025

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

IPD data related to this project will be only for publication purposes.

IPD Sharing Time Frame

30 June 2023 to 30 April, 2024

IPD Sharing Access Criteria

IPD data related to this project will be only shared through publication.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amputation

Clinical Trials on Prosthetic foot

Subscribe